CDK1 and hepatocellular carcinoma: After consulting two distinct drug-gene interaction databases, we found 18 chemicals that have been tested in HCC cells and have the potential to reverse the gene expression pattern of the protein-coding genes AURKA, CCNB1, CDK1, RRM2, and TOP2A.